Rapid fFN for the TLiIQ System
Hologic, Inc. · Decision date Aug 26, 2026
What did the FDA decide?
FDA records P920048/S030 as a supplement to PMA P920048, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Aug 26, 2026.
FDA approval order statement
to modify the paper release liner used on the backing card for the manufacture of the Rapid fFN Cassette Kit of the TLiIQ System
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Clinical Toxicology
- Decision date
- Aug 26, 2026
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
Regulatory record facts
- Identifier
- P920048/S030
- Regulatory pathway
- PMA supplement
- Applicant
- Hologic, Inc.
- Product code
- LKV
- Decision code
- OK30
- Decision date
- Aug 26, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: ENZYME IMMUNOASSAY, FETAL FIBRONECTIN.
- Applicant
- Hologic, Inc.
- Product code
- LKV
- FDA device class
- 3
Review the original FDA PMA listing for the original approval scope and linked supplements.
FDA decision timeline
P920048/S028 · Related supplement
Rapid fFN for the TLiIQ System
P920048/S029 · Related supplement
Rapid fFN for the TLiIQ System
P920048/S030 received
Application receipt date recorded by FDA.
P920048/S030 · FDA decision
30-Day Notice
Timeline entries are records held by MedtechLedger for P920048. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P920048
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Rapid fFN for the TLiIQ SystemP920048/S028 | Hologic, Inc. | PMA supplement | Mar 5, 2026 | FDA |
Rapid fFN for the TLiIQ SystemP920048/S029 | Hologic, Inc. | PMA supplement | Mar 5, 2026 | FDA |
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Hologic, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 1240 Elko Dr., Sunnyvale, CA, 94089
Sources and methodology
- Original FDA record: P920048/S030
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 20, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records
